Drdgold Limited (GB:0ICU)

Drdgold (0ICU) Stock Price & Analysis


0ICU Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.74 - $13.64
Previous Close$11.1
Average Volume (3M)1.55K
Market Cap
Enterprise Value$846.92M
Total Cash (Recent Filing)$151.40M
Total Debt (Recent Filing)$52.30M
Price to Earnings (P/E)N/A
Sep 05, 2023
EPS EstimateN/A
0.26 (2.37%)
Share Statistics
Shares Outstanding85,797,644
10 Day Avg. Volume159
30 Day Avg. Volume1,547
Standard Deviation0.23
Financial Highlights & Ratios
Price to Book (P/B)0.28
Price to Sales (P/S)0.18
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.62
Enterprise Value/EbitdaN/A
Price Target Upside35.10% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1




What was Drdgold Limited’s price range in the past 12 months?
Drdgold Limited lowest stock price was $4.74 and its highest was $13.64 in the past 12 months.
    What is Drdgold Limited’s market cap?
    Currently, no data Available
    When is Drdgold Limited’s upcoming earnings report date?
    Drdgold Limited’s upcoming earnings report date is Sep 05, 2023 which is in 99 days.
      How were Drdgold Limited’s earnings last quarter?
      Drdgold Limited released its earnings results on Feb 15, 2023. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of N/A by $0.36.
        Is Drdgold Limited overvalued?
        According to Wall Street analysts Drdgold Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Drdgold Limited pay dividends?
          Drdgold Limited pays a Semiannually dividend of $0.08 which represents an annual dividend yield of 2.19%. See more information on Drdgold Limited dividends here
            What is Drdgold Limited’s EPS estimate?
            Drdgold Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Drdgold Limited have?
            Currently, no data Available
            What happened to Drdgold Limited’s price movement after its last earnings report?
            Drdgold Limited reported an EPS of $0.36 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.046%.
              Which hedge fund is a major shareholder of Drdgold Limited?
              Among the largest hedge funds holding Drdgold Limited’s share is Gamco Investors, Inc. ET AL. It holds Drdgold Limited’s shares valued at N/A.


                Drdgold Stock Smart Score

                The Drdgold Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Drdgold Limited

                DRDGOLD Ltd. engages in the business of retreatment of surface gold. It operates through the following segments: Ergo, FWGR, and Other Reconciling Items. The Ergo segment treats slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields. The FWGR segment focuses on the slime dams in the West Rand goldfields. The company was founded on February 16, 1895 and is headquartered in Rosebank, South Africa.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Sibanye Stillwater
                Harmony Gold Mining

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis